SRTANasdaqServices-Health ServicesUS GAAP · USD

Strata Critical Medical, Inc.

Strata Critical Medical, Inc. is a U.S.-based time-critical logistics and medical services company focused on the transplant ecosystem. Through its Trinity Medical Solutions and Keystone Perfusion Services brands, it provides air and ground organ transport, organ placement, surgical organ recovery, normothermic regional perfusion, and perfusion staffing and equipment support.

Revenue197m USD
−20.7 %y/y
Operating profit (EBIT)-22.4m USD
+34.1 %y/y
EBIT margin-11.3%
+2.3 ppy/y
Net income41.3m USD
+251.4 %y/y
Free cash flow-58.5m USD
−75.2 %y/y

Fiscal year 2025 · change from previous year

Development 2020–2025

-1000100200300m USD2020: 23 m USD2020: EBIT -0.68 m USD20202021: 51 m USD2021: EBIT -24 m USD20212022: 146 m USD2022: EBIT -54 m USD20222023: 225 m USD2023: EBIT -68 m USD20232024: 249 m USD2024: EBIT -34 m USD20242025: 197 m USD2025: EBIT -22 m USD2025197-22
RevenueOperating profit (EBIT)

Business

Share of revenue
Transplant logistics45 %

Air and ground transport, scheduling, and chain-of-custody services for organ recovery and transplant.

Organ placement services15 %

Administrative support for evaluating donor organs and coordinating acceptance decisions.

Clinical transplant services25 %

Surgical organ recovery, normothermic regional perfusion, and related clinical support.

Perfusion staffing and equipment15 %

Staffing and equipment solutions for cardiovascular surgery centers and hospitals.

Customers

Strata sells directly to transplant centers, organ procurement organizations, hospitals, and other healthcare businesses that need time-sensitive transplant logistics or clinical support. Its services are used when organ offers, recovery, transport, and perfusion must be coordinated quickly and reliably, often under urgent clinical timelines.

Transplant centers

Buy organ transport, placement, recovery, and NRP services to increase transplant throughput and reduce coordination burden.

Organ Procurement Organizations (OPOs)

Use surgical recovery, preservation, and logistics services to manage donor organ recovery and delivery.

Hospitals and health systems

Purchase perfusion staffing, equipment, and related clinical support for cardiac surgery and transplant cases.

Cardiovascular surgery centers

Buy perfusion personnel and equipment on a contractual basis for operating-room support.

Strategy

Strata’s strategy is to offer an integrated “one call” solution that combines logistics and clinical services around transplant cases. It also aims to broaden use of its network by adding adjacent services such as organ placement, NRP, and perfusion staffing, which deepen customer relationships and increase the value of each case.

Integrated transplant platformMedium term

Combining transport, recovery, placement, and perfusion improves customer convenience and differentiation.

Service expansion around transplant workflowsMedium term

Adjacent services increase share of wallet and make the company more embedded in the transplant ecosystem.

Technology-enabled executionShort term

Software and tracking tools support reliability, compliance, and coordination in time-sensitive cases.

Geography

Q2/2025

Strata’s business is concentrated in the United States, where it operates a nationwide network for transplant logistics and surgical services. Its air and ground operations span many locations across the country, which matters because organ transport is highly time-sensitive and depends on aircraft availability, routing, and local clinical resources.

United States88 %
Other countries (US filing)12 %

Share of the revenue the company reports by geography.

Risks

Strata depends on winning and retaining medical customers in a highly competitive, time-critical market where service reliability and pricing are central. Its business is also exposed to operational, reputational, technology, and clinical-liability risks because failures in transport, staffing, or data systems can directly disrupt transplant and surgical workflows.

Sorted by severity
LowMediumHighLowMediumHighImpact →Likelihood →Customer concentration and retention in transplant logistics1Operational failure in time-critical transport2Technology and cybersecurity disruption3Clinical liability and reputational damage4Competition from bundled device and logistics providers5
Impact is the risk’s severity and likelihood how probable it is over the next few years, both assessed from the company’s reports. Numbers match the list.
  1. Customer concentration and retention in transplant logisticsImpact: HighLikelihood: Medium

    Revenue depends on securing medical customers and expanding services with existing accounts.

    ExposureTransplant centersOPOsHospitals
  2. Operational failure in time-critical transportImpact: HighLikelihood: Medium

    Organ cases require rapid dispatch, aircraft availability, and precise coordination.

    Exposure: Air and ground logistics

  3. Technology and cybersecurity disruptionImpact: HighLikelihood: Medium

    Logistics coordination, data tracking, and customer interfaces are essential to service delivery.

    Exposure: Cloud-hosted systems and chain-of-custody tools

  4. Clinical liability and reputational damageImpact: HighLikelihood: Medium

    Surgical recovery, perfusion, and NRP services can lead to claims, investigations, or negative publicity.

    Exposure: Clinical segment

  5. Competition from bundled device and logistics providersImpact: MediumLikelihood: Medium

    Organ preservation equipment makers may also offer transport and clinical services.

    Exposure: Transplant ecosystem

Accounting

Judgemental items
Revenue recognition by contract type

Services are sold on per-case, retainer, and contractual bases, which affects when revenue is recorded.

Impact: Timing and quarterly comparability

Business combinations and contingent consideration

Acquisitions can create fair value estimates and future payment obligations.

Impact: Purchase accounting, liabilities, and earnings volatility

Stock-based compensation

PSUs vest based on multi-year performance metrics such as revenue, Adjusted EBITDA, and free cash flow.

Impact: Non-cash expense and dilution

Goodwill and intangible asset impairment

Acquired clinical and logistics businesses may carry significant intangible assets.

Impact: Potential non-cash write-downs

Publicly listed companies with a comparable business focus.

Last updated: 24/09/2026

Strata Critical Medical, Inc. (SRTA) Revenue, Earnings & Financials 2025 – Clarifo